JPRN-jRCTs052210188
Active, not recruiting
Phase 2
A phase II study Investigating the efficacy and safety of polyglycolic acid sheet for the prevention of infectious complication after laparoscopic surgery for gastric cancer
Obama Kazutaka0 sites210 target enrollmentMarch 8, 2022
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Intraperitoneal infectious complications
- Sponsor
- Obama Kazutaka
- Enrollment
- 210
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Pathologically diagnosed gastric adenocarcinoma
- •2\)Laparoscopic/Robotic distal gastrectomy or total gastrectomy was performed
- •3\)Clinical Stage I \- III
- •4\)Aged 18 \- 85 years
- •5\)Male and Female
- •6\)ECOG Performance Status (PS) 0\-1
- •7\)Written informed consent was obtained
Exclusion Criteria
- •1\)Distant metastasis, invasion to other organs, or spread to esophagus
- •2\)Neoadjuvant chemotherapy
- •3\)Past history of irradiation to upper abdomen
- •4\)Past history of upper abdominal surgery
- •5\)Combined surgery for other diseases other than cholecystectomy
- •6\)Severe infectious disease or other comorbidities
- •7\)Sever drug allergy
- •8\)Immune\-suppressing drug or steroid use
- •9\)Peritoneal dialysis or Hemodialysis
- •10\)Multiple antiplatelet/ anticoagulant drug use or warfarin use
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
PGL5001 Proof of Concept study in inflammatory endometriosisEUCTR2012-001219-22-PLPregLem S.A.
Recruiting
Phase 2
A Phase II Study to Investigate the Efficacy and Safety of Oral intake of Anamorelin in Patients After Total GastrectomyAfter Total GastrectomyJPRN-jRCTs041230012Bando Etsuro65
Active, not recruiting
Phase 1
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000015841Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-005115-41-HUTransgene S.A.39
Active, not recruiting
Phase 1
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-005115-41-BETransgene S.A.44
Active, not recruiting
Phase 1
A study assessing the combination of TG4010 and nivolumab with standard treatment in patients with advanced non small cell lung cancer.Stage IIIB-IV non small cell lung cancer (NSCLC)MedDRA version: 20.0Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-005115-41-DKTransgene S.A.39